Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
  1. 4 Planned sale Henn Matthew R. sold 891 shares at $0.94 ($838)
  2. 4 Planned sale Ege David S. sold 1,090 shares at $0.94 ($1,025)
  3. 4 Planned sale Chief Legal Officer and EVP sold 843 shares at $0.94 ($792)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Planned sale Chief Legal Officer and EVP sold 3,939 shares at $1.08 ($4,254)
  14. 4 Planned sale CEO and President sold 11,549 shares at $1.08 ($12,473)
  15. 4 Planned sale Henn Matthew R. sold 4,170 shares at $1.08 ($4,504)
  16. 4 Planned sale Young Teresa L. sold 3,374 shares at $1.08 ($3,644)
  17. 4 Planned sale von Moltke Lisa sold 4,400 shares at $1.08 ($4,752)
  18. 4 Planned sale Ege David S. sold 5,010 shares at $1.08 ($5,411)
  19. 4 Planned sale Chief Financial Officer sold 3,939 shares at $1.08 ($4,254)
  20. 4 Planned sale Cloghessy Paula sold 2,904 shares at $1.35 ($3,920)

Page 6 of 19 · 380 filings